BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6436830)

  • 1. The effect of methylmercuric chloride on arachidonic acid metabolism by platelet lipoxygenase.
    Ally AI; Miller DR
    Prostaglandins Leukot Med; 1984 Aug; 15(2):209-21. PubMed ID: 6436830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid.
    Aharony D; Smith JB; Silver MJ
    Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Lipoxygenase in human platelets.
    Wong PY; Westlund P; Hamberg M; Granström E; Chao PH; Samuelsson B
    J Biol Chem; 1985 Aug; 260(16):9162-5. PubMed ID: 3926763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6,7,4'-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes.
    Kuhl P; Shiloh R; Jha H; Murawski U; Zilliken F
    Prostaglandins; 1984 Dec; 28(6):783-804. PubMed ID: 6441190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets.
    Dragan YP; Ellis EF
    Biochem Pharmacol; 1990 Jan; 39(1):27-32. PubMed ID: 2105095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 4,7,10,13,16-docosapentaenoic acid by human platelet cyclooxygenase and lipoxygenase.
    Milks MM; Sprecher H
    Biochim Biophys Acta; 1985 Jun; 835(1):29-35. PubMed ID: 3924108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
    Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
    Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibitors of platelet arachidonic acid metabolism: aggregation independent of lipoxygenase.
    Sams AR; Sprecher H; Sankarappa SK; Needleman P
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():19-28. PubMed ID: 6211951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the arachidonate lipoxygenase pathway in blood platelet aggregation.
    Dutilh CE; Haddeman E; ten Hoor F
    Adv Prostaglandin Thromboxane Res; 1980; 6():101-5. PubMed ID: 6770586
    [No Abstract]   [Full Text] [Related]  

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-lipoxygenase from rat PMN lysate.
    Skoog MT; Nichols JS; Wiseman JS
    Prostaglandins; 1986 Mar; 31(3):561-76. PubMed ID: 3012653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase.
    Siegel MI; McConnell RT; Abrahams SL; Porter NA; Cuatrecasas P
    Biochem Biophys Res Commun; 1979 Aug; 89(4):1273-80. PubMed ID: 115466
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of methylmercury and trimethyltin on cardiac, platelet, and aorta eicosanoid biosynthesis and platelet serotonin release.
    Ally A; Buist R; Mills P; Reuhl K
    Pharmacol Biochem Behav; 1993 Mar; 44(3):555-63. PubMed ID: 8451259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and effects of some garlic components on platelet aggregation and metabolism of arachidonic acid in human blood platelets.
    Srivastava KC; Justesen U
    Wien Klin Wochenschr; 1989 Apr; 101(8):293-9. PubMed ID: 2499123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets.
    Schafer AI; Turner NA; Handin RI
    Biochim Biophys Acta; 1982 Sep; 712(3):535-41. PubMed ID: 6812645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro.
    Dutilh CE; Haddeman E; Don JA; ten Hoor F
    Prostaglandins Med; 1981 Feb; 6(2):111-26. PubMed ID: 6787628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of an assay for studying the effects of agents on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in washed human platelets.
    Dragan YP; Ellis EF
    Prostaglandins Leukot Essent Fatty Acids; 1990 Feb; 39(2):105-9. PubMed ID: 2111551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the formation of the platelet lipoxygenase product from endogenous arachidonic acid.
    Hwang DH
    Lipids; 1982 Dec; 17(12):845-7. PubMed ID: 6819423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
    Barradas MA; Jeremy JY; Kontoghiorghes GJ; Mikhailidis DP; Hoffbrand AV; Dandona P
    FEBS Lett; 1989 Mar; 245(1-2):105-9. PubMed ID: 2494068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.